Peptide-based vaccine design against Hendra virus through immunoinformatics approach

Area of Science:

• Veterinary Virology
• Immunology
• Bioinformatics

Background:

• Hendra virus (HeV) causes severe respiratory and neurological diseases in animals.
• Human infections with HeV are rare but have high fatality rates.
• Current vaccines and therapies against HeV are lacking.

Purpose of the Study:

• To design and evaluate an in-silico multi-epitope vaccine against Hendra virus.
• To identify potential B and T cell epitopes from the HeV proteome.
• To assess the immunogenic and structural properties of the designed vaccine.

Main Methods:

• Proteome analysis of Hendra virus.
• Immunoinformatics for selecting B and T cell epitopes.
• In-silico vaccine construct design incorporating epitopes, linkers, and adjuvants.
• Molecular docking and dynamic simulations for stability and interaction analysis.

Main Results:

• Selected epitopes demonstrated high antigenic properties and immune receptor interaction potential.
• Molecular docking revealed strong interactions between the vaccine and Toll-like receptor 5.
• Molecular dynamics simulations confirmed the structural and dynamic stability of the vaccine construct.
• In-silico immune simulations predicted activation of B and T cells, leading to antibody and cytokine production.

Conclusions:

• The designed multi-epitope vaccine exhibits promising non-toxic, non-allergic, and highly immunogenic properties.
• The vaccine construct shows potential for eliciting a robust immune response against Hendra virus.
• Further experimental validation is required to confirm the efficacy of this in-silico designed vaccine.